To view more news and media here in our Newsroom

Click Here

Innovative Stem Cell Therapeutic Strategy May be Transformative for Heart Failure Treatment

Washington, D.C.,  – The FDA has recently approved an investigational new drug clinical trial that will start shortly at MedStar Heart & Vascular Institute. The trial, called STEMVAD, is sponsored by MedStar Heart, in partnership with CardioCell, to determine whether stem cell therapy improves myocardial function in patients with severe heart failure—severe enough to require the implantation of a left ventricular assist device, or LVAD. The trial will use CardioCell’s proprietary mesenchymal stem cells (MSCs), and will pioneer the use of a novel delivery strategy, deriving from a new understanding of the causes of progressive heart failure and the mechanisms…

Read More

TAVR Clinical Trial Provides ‘Strong Signal’ Procedure is Safe for Patients with Low Surgical Mortality Risk

Patients Undergoing Transcatheter Aortic Valve Replacement Showed No Deaths or Disabling Strokes within 30 days of Undergoing Less Invasive Procedure

Read More

MedStar Washington Hospital Center First in D.C. to Use Mobile Intraoperative CT Scanner for Neurosurgery

Washington, D.C., August 14, 2018 – MedStar Washington Hospital Center is the first hospital in Washington, D.C., to use the Brainlab Airo® Mobile Intraoperative CT, an advanced imaging scanner that gives surgeons a real-time look at the brain or spine during surgery in order to make immediate decisions when it counts the most. Thirty patients have been treated so far at the Hospital Center using the system’s synchronized imaging capabilities. The portable scanner produces high-quality CT images of the patient’s brain or spine in the operating room, allowing surgeons to clearly see their exact position and make the most precise…

Read More

WATCHMAN FLX™ in Clinical Trial at MedStar Heart & Vascular Institute

Study of Stroke Prevention Device Which May Give Physicians More Flexibility in Optimal Cardiac Positioning  Washington, D.C., June 12, 2018 – MedStar Heart & Vascular Institute physicians participating in a clinical trial have become the first in the Mid-Atlantic region to implant the next generation of a potentially life-changing device proven to reduce the risk of stroke in certain patients with atrial fibrillation (AFib). The next-generation device, called the WATCHMAN FLX™, is being studied for its ability to provide doctors with greater flexibility and safety while positioning the device in the left atrial appendage, a sub-chamber of the heart where…

Read More

Top News
Innovative Stem Cell Therapeutic Strategy May be Transformative for Heart Failure Treatment
News
Innovative Stem Cell Therapeutic Strategy May be Transformative for…
Close
How Can
We Help You?

Begin your search for a physician, service or location.

Find a Doctor

Our full team of professionals is here for you.

Find a Doctor

Call Us Today

For an appointment or referral and to open the door to a healthier future.

202-877-DOCS

Maps & Directions

For directions to MedStar Washington Hospital Center, parking information and more.

Getting Here